Literature DB >> 28254833

Yellow fever vaccine-associated neurological disease, a suspicious case.

Pedro Beirão1, Patrícia Pereira1, Andreia Nunes1, Pedro Antunes2.   

Abstract

A 70-year-old man with known cardiovascular risk factors, presented with acute onset expression aphasia, agraphia, dyscalculia, right-left disorientation and finger agnosia, without fever or meningeal signs. Stroke was thought to be the cause, but cerebrovascular disease investigation was negative. Interviewing the family revealed he had undergone yellow fever vaccination 18 days before. Lumbar puncture revealed mild protein elevation. Cultural examinations, Coxiella burnetti, and neurotropic virus serologies were negative. Regarding the yellow fever virus, IgG was identified in serum and cerebrospinal fluid (CSF), with negative IgM and virus PCR in CSF. EEG showed an encephalopathic pattern. The patient improved gradually and a week after discharge was his usual self. Only criteria for suspect neurotropic disease were met, but it's possible the time spent between symptom onset and lumbar puncture prevented a definite diagnosis of yellow fever vaccine-associated neurological disease. This gap would have been smaller if the vaccination history had been collected earlier. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28254833      PMCID: PMC5353478          DOI: 10.1136/bcr-2016-218706

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Zika virus infection elicits auto-antibodies to C1q.

Authors:  Takaaki Koma; Veljko Veljkovic; Danielle E Anderson; Lin-Fa Wang; Shannan L Rossi; Chao Shan; Pei-Yong Shi; David W Beasley; Natalya Bukreyeva; Jeanon N Smith; Steven Hallam; Cheng Huang; Veronika von Messling; Slobodan Paessler
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

Review 2.  A clinician's perspective on yellow fever vaccine-associated neurotropic disease.

Authors:  Elien Lecomte; Guy Laureys; Frederick Verbeke; Cristina Domingo Carrasco; Marjan Van Esbroeck; Ralph Huits
Journal:  J Travel Med       Date:  2020-11-09       Impact factor: 8.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.